VSJ-110
VP-VSJ-110-2202
Phase 2 small_molecule active
Quick answer
VSJ-110 for Dry Eye is a Phase 2 program (small_molecule) at Vanda Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Dry Eye
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active